Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 6/20 | 0.35 |
| ▸ | JAK1 | P23458 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29638310 | 0.92 | ALDH1A1 (0.40) | TYK2JAK1TP53PLK1ALDH1A1 | |
| SCHEMBL24557308 | 0.90 | TYK2 (0.40) | TYK2JAK1TP53PLK1ALDH1A1 | |
| SCHEMBL29638404 | 0.90 | TYK2 (0.40) | TYK2JAK1TP53PLK1ALDH1A1 | |
| SCHEMBL29638350 | 0.86 | PHGDH (0.36) | TYK2JAK1TP53PLK1 | |
| SCHEMBL24557356 | 0.86 | PHGDH (0.36) | TYK2JAK1TP53PLK1 | |
| SCHEMBL24557361 | 0.85 | MAPT (0.45) | TYK2PLK1POLBMAPT | |
| SCHEMBL29638475 | 0.85 | AXL (0.39) | TYK2 | |
| SCHEMBL24557258 | 0.85 | NPC1 (0.41) | TYK2TP53ALDH1A1POLBMAPT | |
| SCHEMBL29638464 | 0.85 | NPC1 (0.41) | TYK2TP53ALDH1A1POLBMAPT | |
| SCHEMBL24557263 | 0.85 | TYK2 (0.39) | TYK2JAK1PLK1ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022136914-A1 | TYK2 INHIBITORS AND USES THEREOF | SUDO BIOSCIENCES LIMITED (GB) | 2022-06-30 | — | — | WO | disclosed |